跳至主要内容
临床试验/JPRN-UMIN000003503
JPRN-UMIN000003503已完成未知

An open label, randomized control study for the comparison of effectiveness between Alfa-Glucosidase inhibitor and Dipeptidyl peptidase-4 (DPP-4) inhibitor in people with type 2 diabetes treated diet therapy and/or single oral hypoglycemic agent - An open label, randomized control study for the comparison of effectiveness between Alfa-Glucosidase inhibitor and Dipeptidyl peptidase-4 (DPP-4) inhibitor in people with type 2 diabetes treated diet therapy and/or single oral hypoglycemic agent

Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Science0 个研究点目标入组 260 人开始时间: 2010年4月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
260

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.None Type 2 diabetes 2.Medical history and/or complication of diabetic ketoacidosis 3.Medical history and/or complication of severe hypoglycemia 4.Insulin treatment within 16 weeks prior to the study 5.Treatment with Alfa-glucosidase inhibitors or sitagliptin within 12 weeks prior to the study 6.Treatment with glucocorticoid 7.Unstable glycemic contol 8.Hypersensitivity to or contraindication of sitagliptin and voglibose 9.AST or ALT >=2.5 time of institutional upper normal limit 10.Uncontrolled hypertension(systolic blood pressure >160mmHg or diastolic blood pressure >100mmHg) 11.Severe health problems not suitable for the study 12.Pregnant or lactating women

研究者

发起方
Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Science

相似试验